Cite
MLA Citation
George Laszlo et al.. “Erratum to: High expression of myocyte enhancer factor 2C (MEF2C) is associated with adverse-risk features and poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.” Journal of hematology & oncology, vol. 9, no. 1, 2016, p. 1. http://access.bl.uk/ark:/81055/vdc_100080937761.0x0000c3